Credit Agricole’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Credit Agricole’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-385	Closed	-$24K	–	1682
2014 Q2	$24K	Sell	385 -1,144	-75%	-$66.5K	﹤0.01%	1547
2014 Q1	$99K	Buy	+1,529	New	+$103K	﹤0.01%	1367

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Credit Agricole's OREX Position: Q3 2014 in Review

Credit Agricole sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2014, closing a stake of 385 shares — an estimated $24K sold.

Credit Agricole first reported a position in OREX in Q1 2014 and held it in 2 quarters. The position peaked at $99K in Q1 2014. 128 funds tracked by Wall St. Rank hold OREX as of Q3 2014.

Credit Agricole reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
Credit Agricole sold 385 Orexigen Therapeutics, Inc. shares in Q3 2014, an estimated $24K.
Credit Agricole first reported a position in Orexigen Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
Credit Agricole's Orexigen Therapeutics, Inc. position peaked at $99K in Q1 2014.
128 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2014.

Based on Credit Agricole's 13F filing for Q3 2014, filed 13 Nov 2014.